Ticker

Analyst Price Targets — CARL

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 6, 2026 9:10 amRichard NewitterTruist Financial$20.00$13.56StreetInsider Carlsmed Inc (CARL) PT Raised to $20 at Truist Securities
July 1, 2026 9:56 amDavid SaxonNeedham$17.00$10.38TheFly Carlsmed initiated with a Buy at Needham
April 15, 2026 12:25 pmTruist Financial$18.00$10.80TheFly Carlsmed price target lowered to $18 from $20 at Truist
January 9, 2026 10:49 amGoldman Sachs$20.00$12.87TheFly Carlsmed price target raised to $20 from $19 at Goldman Sachs
December 15, 2025 10:54 amRyan ZimmermanBTIG$24.00$12.95StreetInsider BTIG Reiterates Buy Rating on Carlsmed Inc (CARL)
August 18, 2025 8:49 amMatt O'BrienPiper Sandler$18.00$13.58TheFly Carlsmed initiated with an Overweight at Piper Sandler

Latest News for CARL

Carlsmed Q2 Earnings Call Highlights

Carlsmed NASDAQ: CARL reported second-quarter 2026 revenue of $18.9 million, up 57% from $12.1 million a year earlier, as growth in its aprevo lumbar platform and contributions from its newer cervical offering lifted procedure volumes.

MarketBeat • Aug 5, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CARL.

No House trades found for CARL.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top